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The mammary gland is one of few organs that continues to develop postnatally, 
through puberty, pregnancy, lactation and involution. Interestingly, these times of 
development are also considered windows of susceptibility for future development of 
breast cancer. Studies have shown that processes important in mammary gland 
development are often deregulated during breast cancer tumorigenesis.  
Advanced glycation end products (AGEs) are highly reactive metabolites 
produced during normal metabolism. AGE content in the Western Diet has consistently 
increased over the years and accumulation of AGEs in the body leads to pro-
inflammatory and pro-oxidant effects. Diet, including a diet high in fat has been shown to 
deregulate mammary development and lead to increased breast cancer risk. This study 
examines the impact of a diet high in AGEs on pubertal mammary gland development in 
mice. Mice were fed a control and high AGE diet from onset of puberty (3 weeks) to 
experimental endpoints of 7, 8 (pubertal) and 12 weeks (adulthood). At each 
experimental endpoint blood was collected for analysis of circulating AGEs and 
mammary gland tissue was collected for whole mounting, immunohistochemistry of 
AGE, RAGE, Ki67, αSMA, and F4/80 as well as morphology with hematoxylin and eosin 
(H&E). Mice fed the high AGE diet showed increase ductal branching, terminal end bud 
(TEB) number and size, as well as a delay of ductal extension. Immunohistochemistry 
techniques showed increased proliferation (Ki67) and disruption of myoepithelial layer 
(αSMA) in mice fed a high AGE diet. Histology revealed changes in morphology of gland 
structures, increased recruitment of stromal cells surrounding ductal/TEB structures, 
including macrophages and activated fibroblasts, as well as the formation of pre-
neoplastic like lesions in adulthood with mice fed a high and low AGE diet.  
xiii 
 
In summary, we observed a significant disruption of normal pubertal mammary 
gland development in mice fed a high AGE diet when compared to mice fed a control 
diet, possibly leading to increased breast cancer risk in adulthood. 
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Introduction and Background 
Advanced Glycation End-Products. 
Advanced glycation end-products (AGEs) are reactive metabolites formed via normal 
metabolism through a reaction commonly known as the Maillard reaction (Figure 1). This 
reaction occurs in a series of three phases: the first being glycation, or the reversible 
non-enzymatic reaction causing the addition of reducing sugars to the amino groups on 
biological macromolecules, such as: proteins, lipids or nucleic acids. This leads to the 
formation of Schiff bases. The second step involves a series of reversible 
rearrangements of the Schiff bases to form early glycation precursors, or Amadori 
products. Accumulation of these early glycation precursors leads to further 
rearrangements irreversibly forming AGE reactive metabolites [1-5]. 
The Maillard reaction, while the main source of AGE formation in the body is not 
the only pathway leading to the formation of these reactive metabolites (Figure 1). 
Autoxidation of glucose and the peroxidation of lipids by increase oxidative stress lead to 
the formation of dicarbonyl derivatives, known as α-oxaldehydes. These derivatives can 
interact with monoacids to form AGEs. Glucose can also be converted to sorbitol by 
aldose reductase and then to fructose by sorbitol dehydrogenase, a reaction known as 
the polyol pathway. Fructose metabolites can then be converted to α-oxaldehydes, 
which again can interact with monoacids and form AGEs. Given the different pathways 













Figure 1. Mechanisms of AGE Formation. Endogenous formation of AGEs can 
occur through a variety of mechanisms. The Maillard reaction being the classic 
pathway, but AGEs can also be formed through glucose autooxidation, lipid 
peroxidation, and the polyol pathway. Taken from “Dietary Advanced Glycation End 
Products and Aging” by C. Luevano-Contreras and K. Chapman-Novakofski, 2010, 




AGEs are naturally found in uncooked foods, but AGE content can be 
accelerated by cooking methods, such as grilling, broiling and searing, which has shown 
to induce the greatest AGE formation [1, 4-6]. Processed foods treated for preservation 
can also increase AGE content in sugar laden foods [6]. AGEs are also being added 
directly to highly processed foods to increase appearance and taste as we have 
developed overtime to enjoy the taste of AGEs [1, 4-6]. Cigarettes and processed 
 
Figure 2. Variety in AGE Structure. Structures of various low molecular weight 
(LMW) and high molecular weight (HMW) AGEs derived from the amino acids lysine, 
arginine, or both showing variation of AGE formation on structure. Initial intermediate 
products of AGE formation are shown in the middle, with the structure of common 
reducing sugars with their degradation and fragmentation products. Taken from 
“Advanced glycation end-products in food and their effects on health.” by M. Poulsen 
et al., 2013, Food and Chemical Toxicology 60: 10-37. 
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tobacco smoking are also an exogenous source of AGEs, as glycotoxins inhaled can be 
transported into the blood stream and thereby contribute to AGE formation [1-5]. 
The Western diet generally consists of a diet that is high in sugar, fat and 
processed foods, it has become more prevalent over the years and shown to contribute 
to the dramatic increase of obesity and type 2 diabetes [7]. These foods have also been 
shown to have a high AGE content. Along with an increase in western diet, sedentary 
lifestyle has also risen, further contributing to the accumulation of AGEs in the body as 
an active lifestyle was shown to decrease AGEs in the circulation [1-6, 8]. 
AGE Reduction. A main lifestyle intervention aimed at reducing AGE accumulation in 
the body is restriction of foods containing a high AGE content [2-6, 9]. Several such 
intervention studies in both animal and human subjects showed that intake of AGEs from 
diet contribute to tissue damage that can be monitored by dietary restriction. Animal 
models such as C. elegans and mice have been shown to have increased lifespan upon 
caloric restriction leading to decrease in AGE accumulation and oxidative stress [3, 4, 8, 
9]. Exercise has also been shown to lead to a decrease in AGE accumulation in both 
animal and human models, something we have observed in our own clinical trials with 
breast and prostate cancer patients (unpublished observations), while some 
pharmacological interventions such as metformin and Orlistat have shown promising 
results in reduction of AGE formation in pre-clinical and clinical trials, it is unorthodox 
however to distribute such drugs to adolescents without knowing the side-effects [3-6, 9]. 
Antioxidants, such as melanoidins, catechins, proanthocyanidins and phenolic 
antioxidants have also shown a promising role in the reduction of AGE formation and 
oxidative stress, giving adolescents healthier options of AGE reduction [2-6, 9].  
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 Receptor for Advanced Glycation End-Products, AGE Signaling and Cancer. 
 While AGEs can act independently of a receptor, leading to damage of protein structure 
and function, often seen in cross-linking of 
collagen in the extracellular matrix (ECM), 
they can also act as a ligand for the receptor 
of advanced glycation end-products (RAGE) 
[7, 9-13]. RAGE is a pattern recognition 
transmembrane receptor that is a part of the 
immunoglobulin superfamily (Figure 3) [7, 9-
13]. While it is expressed at low levels in all 
tissues on multiple cell types, including 
macrophages and epithelial cells, it can be 
greatly increased in pathophysiological 
settings, such as diabetes, Alzheimer disease 
and cancer [7, 9-14]. Interestingly, RAGE 
signaling in macrophages led to increased 
proliferation, recruitment and maturation [7, 9-13].  
 Once AGE binds to RAGE, downstream signaling pathways such as 
phosphatidylinositol-3-kinases (PI3K) and mitogen activated protein kinases (MAPK) 
become activated and lead to the translocation of nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) [7, 9-13]. The activation of the transcription factor 
NF-κB leads to the production and release of inflammatory cytokines, growth factors, 
and adhesive molecules, which lead to the recruitment of immune cells [7, 9-13]. AGE 
activation of RAGE also leads to increased expression of RAGE itself, creating a positive 
feedback loop, further enhancing inflammation promoters [9, 11, 13]. Interaction with 
 
Figure 3. RAGE structure. Taken 
from “Receptor for Advanced 
Glycation End Products and 
Atherosclerosis: from Basic 
Mechanisms to Clinical Implications” 




RAGE also leads to the activation of nicotinamide adenine dinucleotide phosphate-
oxidase (NAD(P)H), increasing intracellular oxidative stress, which in response leads to 
activation of NF-κB [7, 9-13]. The role of AGE signaling in inflammation has implicated 
this signaling pathway in the progression of a variety of disorders, including diabetes, 
Alzheimer’s and cardiovascular disease [7, 9-14].  
 A pro-inflammatory environment is associated with promotion of tumorigenesis 
and a poor prognosis. Many cancers such as breast, prostate, colorectal and gastric 
have shown that AGE accumulation is increased and RAGE expression is upregulated in 
cancer tissue compared to normal [9, 13]. As discussed earlier AGE:RAGE signaling 
leads to activation of MAPK and PI3K pathways, both of which are known to be 
upregulated in cancer, promoting increased and uncontrolled growth of malignant tumors 
[9, 10]. Signaling through PI3K, MAPK and NADPH oxidase activation ultimately leads to 
the activation of NF-κB, as stated above [9, 11-13]. The resulting release of cytokines 
and growth factors, promotes increased recruitment of immune cells, increased oxidative 
stress and uncontrolled proliferation. Activation of NF-κB also leads to the increased 
expression of RAGE, leading to a feed-forward loop, further creating a pro-inflammatory 
and pro-oxidative microenvironment and a pro-tumorigenic environment in the presence 




 AGE and RAGE in Macrophages and Fibroblasts. Macrophages are cells of 
the innate immune system that play a crucial role in host defense and tissue 
development. AGE:RAGE signaling leads to the release of cytokines, other inflammatory 
markers and adhesion molecules (ex. IL-1β, TNF-α, iNOS, ICAM-1 and VCAM), leading 
to inflammatory recruitment to a site of infection or injury [7, 9-13, 16]. RAGE is a 
member of the pattern-recognition receptors (PRRs) and can be found on macrophages. 
RAGE ligands, including AGEs leads to activation of macrophages, causing secretion of 
inflammatory markers, toxins and more RAGE ligands, including AGEs [7, 9-13, 16]. The 
receptor is not only shown to play a role in recruitment, proliferation and activation of 
macrophages, but also polarization, or the expression/secretion of different functional 
 
Figure 4. Schematic of AGE:RAGE Signaling. Lifestyle and biological AGEs 
bind to RAGE; PI3K, MAPK and NAD(P)H oxidase are activated downstream 
causing translocation of NF-κB to the nucleus, resulting in enhanced 
transcription and subsequent release of inflammatory markers as well as 
oxidative stress. In excessive presence of AGEs, microenvironment becomes 







































factors in response to signals from the microenvironment [7, 10].  AGE activation of the 
NF-κB pathway through RAGE in diabetes lead to the polarization of macrophages to a 
pro-inflammatory M1 phenotype, with increased expression of IL-6, IL-10, TNF-α, and 
iNOS [7, 10].  
Oxidative/carbonyl stress leads to increased expression of RAGE and other 
inflammatory markers on periodontal fibroblasts leading to increased inflammatory 
response [13, 17, 18]. AGE signaling through RAGE on pancreatic fibroblasts led to the 
activation of NF-κB, leading to increased expression of CCL5, IL-6 and IL-1B genes [17, 
18]. AGE exposure to fibroblasts leads to activation of matrix metalloproteinase-2 (MMP-
2), collagen 1 expression and upregulation of TGF-β1, TNF-α and IL-8 cytokines [13, 17, 
18]. TGF-β1 and AGE crosstalk was shown to stimulate collagen III expression, and 
TGF-β1 signaling alone resulted in stimulation of GM-CSF and IL-6 expression, together 
leading to pro-inflammatory signaling and regulation of ECM turnover [17, 18].  
Mammary Gland Development.  
The mammary gland is a complex secretory organ composed of: epithelial cells, 
adipocytes, endothelial cells, fibroblasts and immune cells [19-22]. The main function of 
the mammary gland or breast is to secrete milk for the nourishment of newborns. The 
gland fulfils its function of supplying adequate milk by forming an extensive and 
functional tree-like structure of branched ducts, filling the majority of the fat pad [19-22]. 
Mammary gland development consists of three main stages; embryonic, pubertal and 
reproductive. Most of the extensive ductal-tree development occurs during adolescence 
[19-22]. While there are some hormonal and architectural differences between human 
and mouse mammary glands, researchers use the mouse as a model system to 
investigate the mechanisms of development as many models are implemented in breast 
cancer development studies as well [19-22]. 
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Pubertal Mammary Gland Development. Pubertal development of the 
mammary gland begins during an extensive hormone-dependent phase of growth 
associated with increased epithelial cell proliferation [19-21]. This stage is associated 
with the formation of TEBs, highly proliferative club-like structures at the ends of ducts 
[23-25]. These bulbous structures form around 3 weeks of age and begin to penetrate 
the fat pad via the proliferation of a single layer of cap cells at the ends of the TEBs and 
the underlying epithelium [23-25]. Cap cells then differentiate into the myoepithelial layer 
surrounding the tubular ductal bilayer as the tree pushes into the mammary fat pad [21-
25]. Proliferation is regulated by growth hormone (GH) inducing the expression of 
insulin-like growth factor-1 (IGF1) in the liver and mammary stromal cells. Acting 
together with estrogen (E2) from the ovary, IGF1 helps to induce epithelial proliferation. 
Acting via a paracrine fashion E2 signals through its receptor, estrogen receptor 1 
(ESR1), to stimulate the release of amphiregulin (AREG), an epidermal growth factor 
(EGF) family member [21, 22]. AREG then binds to its receptor on stromal cells, 
inducing the release of fibroblasts growth factors (FGFs), which stimulate ESR1- luminal 
cell proliferation. Factors such as: TGF-β1, Reelin, Slit2 and Netrin1 leading to either 





Extensive primary duct networks develop via the bifurcation of the TEBs, 
followed by branching of secondary side branches. Secondary branching from primary 
ducts continues until the ductal-tree fills about 60% of the fat pad, leaving space for the 
influence of pregnancy hormones. The mature ductal tree undergoes further branching 
under the influence of cycling ovarian hormones, leading to the formation of short tertiary 
side-branches [19-22]. Once the gland is fully formed at the end of pubertal 
 
Figure 5. Hormonal Signaling During Pubertal Development. Signaling 
pathways during pubertal development leading to cell proliferation and survival of 
luminal epithelial cells of the TEBs leading to development of the ductal tree. Taken 
from “Mammary Gland Development” by H. Macias and L. Hink, 2012, Wiley 
Interdisciplinary Reviews. Developmental Biology, 1(4):533-57.  
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development, highly proliferative TEBs begin to taper off and become quiescent, forming 
terminal end ducts (TEDs) in adulthood (Figure 6) [23-25].  
 
Macrophages/Fibroblasts in Pubertal Mammary Gland Development. 
Macrophages play a crucial role in correct tissue development of the mammary gland 
during puberty [19, 20]. During development, macrophages can normally be found 
around the TEBs, specifically around the neck and inside the TEBs, poised to be 
clearing cellular debris from cells undergoing apoptosis during development (Figure 7) 
[26-32]. Macrophages in resident tissue respond to cytokines in the tissue 
microenvironment during development. Cytokines such as IL-4 and IL-13 have been 
shown to be critical for differentiation of luminal epithelial cells [26-32]. It is believed that 
macrophages recruited to the mammary structures during development release factors 
for epithelial growth, angiogenesis or matrix remodeling, but also consumption of dead 
cells from turnover during development [26-32].  
 
 
Figure 6. Pubertal Mammary Gland Development. Schematic view of pubertal 
mammary gland development from initiation (~3 weeks), to end of puberty (~8 














To show the importance of macrophages in the developing gland, Gouon-Evans 
et al subjected mice to gamma-irradiation leading to depletion of circulating and 
mammary tissue leukocytes. Removal of the leukocytes led to impeded ductal 
development and absence of TEBs at the end of ducts, an overall neonatal look 
compared to control (Figure 8, A & D). When mice were subjected to bone marrow 
transplants, restoration of ductal outgrowth occurred, and the gland appeared more 







Figure 7. Macrophage Recruitment to TEBs. Anti- F4/80 staining of a TEB 
showing the localization of macrophages to the neck of TEBs (A), zoomed in field of 
view (B). Taken from “Requirement of macrophages and eosinophils and their 
cytokines/chemokines for mammary gland development.” by V. Gouon-Evans, EY. 





The colony-stimulating factor 1 receptor (CSF-1R) is expressed on macrophages 
in mouse and human mammary glands during development [28, 29, 33-35]. Macrophage 
colony-stimulating factor 1 (CSF-1), is a growth factor that regulates proliferation, 
recruitment and survival of macrophages as well as other cells of the mononuclear 
phagocytic lineage. Mice with null mutations in CSF1 show a significant reduction of 
macrophages in the mammary gland. The reduction correlated with a delay and 
 
Figure 8. Importance of Macrophages in Development. Representative whole mounts 
of irradiated mice (A) compared to control (B). As well as representative images of mice 
treated with bone marrow transplant (C) or not (D). Taken from “Requirement of 
macrophages and eosinophils and their cytokines/chemokines for mammary gland 




reduction in TEB formation as well as reduced ductal morphogenesis. This phenotype 
was rescued when the mice were treated with human CSF1 (Figure 9) [33-35].  
 
Stromal fibroblasts are located throughout the fat pad and within proximity of the 
epithelial branching tree. Fibroblasts take part in bi-directional communication during 
branching morphogenesis by the release of growth factors, proteases, cytokines and 
other factors, playing an important role in epithelial cell survival and morphogenesis [19, 
21, 31]. Studies have shown that fibroblasts play an important role in mammary ECM, 
 
Figure 9. Importance of Macrophages in Development. TEB number, branching 
number, ductal length and the relative ductal growth in the mammary glands of 
control (squares) and experimental (triangles) mice. Showing significant effect on 
pubertal development in mice lacking macrophages. Taken from “Postnatal 
mammary gland development requires macrophages and eosinophils.” by V. Gouon-
Evans, M. Rothenberg and JW. Pollard, 2000, Development, 127(11):2269-82. 
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synthesizing such components as collagen, proteoglycans, fibronectin, as well as MMPs 
and other enzymes important for the degradation and regulation of the ECM [31].  
Diet and Pubertal Mammary Gland Development. Mouse models of pubertal 
mammary gland development have shown drastic effects on the tightly regulated 
process with exposure to various diets. One of the most studied, is the high fat diet. 
C57BL/6 mice fed a pubertal high fat diet showed reduction in duct length and number of 
TEBs, a sparse ductal tree, increased mammary adiposity and reduced mammary 
epithelial cell proliferation compared to control diet. High fat diet in C57BL/6 mice was 
also shown to reduce E2 responsiveness, a key hormonal factor in the developing gland. 
When BALB/c mice were fed the pubertal high fat diet a similar morphological change 
was observed in the glands. However, BALB/c mice showed increased mammary 
epithelial cell proliferation and reduced E2 responsiveness with no change in adiposity of 
the gland [36, 37]. 
Western diets are known to consist of high n-6 polyunsaturated fatty acids (n-6 
PUFA), while Asian diets are known to consist of high n-3 PUFA. Consumption of n-6 
PUFA during pubertal development of FVB/N and C57BL/6 mice resulted in increased 
TEB number, branching, epithelial cell proliferation compared to n-3 PUFA, which 
showed increase apoptosis mainly in TEBs [38, 39]. 
Breast Cancer.  
A normal functioning mammary gland is responsible for milk production and nourishment 
for newborns after childbirth. Human mammary glands consist of lobules for milk 
production known as lobes, or thin tube shaped structures that lead from the lobes to the 
nipple [20]. Fat and fibrous tissue surrounds the lobes, as blood and lymphatic vessels 
course throughout the breast which play a role in normal function, as well as tumor 
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metastasis [20, 40, 41]. Breast cancer has been ranked as the most common and deadly 
cancer among women. Around 70% of all breast cancer cases are shown to initiate in 
the ductal structures [40, 41].  
 Ductal Carcinoma In-situ (DCIS). Normal ductal structure consists of an outer 
myoepithelial layer and a luminal epithelial layer. The structure is surrounded by ECM 
and various stromal cells, including fibroblasts and macrophages [31]. It is believed that 
breast cancer begins with subtle changes in ductal or lobular epithelium, the structures 
may then develop further and become malignant and ultimately metastatic. This can be 
seen in the slight changes of the organized bi-layer ductal epithelium beginning to exhibit 
changes such as atypia, hyperplasia and ductal occlusion. These highly proliferative 
atypical ductal structures are considered early stage DCIS that have yet to break 
through the basement membrane [40, 42]. DCIS is also characterized with changes in 
the ECM and stromal cell recruitment. Myoepithelial cells can be altered and decreased 
potentially because of signals coming from tumor epithelial and stromal cells. The 
number of stromal cells, such as fibroblasts, myofibroblasts, macrophages, and 
endothelial cells increase, and continue to increase as the tumor growth and aggression 
continues. These early lesions are considered a risk factor for development of invasive 
breast cancer or invasive ductal carcinoma (IDC) (Figure 10) [40, 42, 43]. About 60,000 
cases a year or 20% of all breast cancer diagnoses in the United States are considered 
DCIS [41]. Interestingly, aberrant activation of NF-κB by transgenic mouse model 
showed that this known downstream factor of AGE:RAGE signaling leads to the 
formation of DCIS like structures, possibly by the increased and sustained immune 





 Macrophages/Fibroblasts in Breast Cancer. Macrophages not only play an 
important role in the developing gland, but also in the microenvironment of breast cancer 
during its progression [26, 27, 31, 44, 45].  Because of this, increased macrophage 
presence in biopsies has been linked to increased recurrence and decreased overall 
patient survival [41]. Classically activated macrophages or M1 macrophages are 
activated by cytokines such as interferon-γ, producing pro-inflammatory cytokines that 
aid in helper T-cell type 1 response. Tumor associated macrophages or TAMs are 
believed to be M2 macrophages or alternatively activated macrophages. They are 
activated by helper T-cell type 2 cytokines: IL-4, IL-10 and IL-13. TAMs secrete factors 
such as VEGF, EGF, FGFs and CXCL1/2 aiding in tumor progression and survival by 
inducing angiogenesis, cell survival and migration [40, 44, 45]. These macrophages 
have also been shown to interact with the ECM releasing pro-tumorigenic factors which 
suppresses CD4+ and CD8+ T lymphocytes anti-tumor function. Production of these 
 
Figure 10. Progression of DCIS and Microenvironment Changes. 
Microenvironmental alterations during tumor progression from normal breast to DCIS to 
IDC and ultimately metastatic breast carcinoma. Taken from “The Role of the 
Microenvironment in Mammary Gland Development and Cancer” by K. Polyak and R. 
Kalluri, 2010. Cold Spring Harbor Perspectives in Biology, 2:a003244. 
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factors and changes to the ECM have also shown to promote breast cancer resistance 
to certain chemotherapeutic drugs [40, 44, 45].  
 Fibroblasts are the most abundant stromal cells in the mammary gland and play 
an important role in regulation of ECM during development [31]. Fibroblasts have also 
been shown to play an important role in cancer, called cancer-associated fibroblasts 
(CAFs) [40, 45, 46]. CAFs are similar to activated fibroblasts in wound healing, 
commonly associated with increased expression of α-SMA, the ED-A splice of 
fibronectin and other markers. Origins of CAFs are believed to be from activated 
fibroblasts, bone marrow derived mesenchymal stem cells (MSCs) or from cancer cells 
that undergo epithelial-mesenchymal transition (EMT) [40, 45-47]. CAFs have been 
shown to promote tumor onset and progression in a variety of ways, including, effects on 
E2 levels, secretion of factors (HGF, TGF-β, SDF-1, VEGF, IL-6, MMPs, etc.), inducing 
stemness, EMT and epigenetic modifications. Interestingly, CAFs are induce invasion 
and metastasis in breast cancer [45, 47, 48]. In DCIS, CAFs induce the invasive 
capabilities of epithelial cells in vitro and in vivo through increased MMP14 expression 
and MMP9 activity [45, 46]. CAFs, with the aid of other stromal cells, also induce EMT 
changes in mammary gland epithelial cells, angiogenesis and macrophage recruitment 
[45, 47, 48].  
Windows of Susceptibility. The ‘lifecycle’ of mammary gland development can be 
divided into five windows of cancer susceptibility: in utero, pubertal, pregnancy, 
postpartum involution and age-related involution.  Each of these windows is limited in 
duration, making the at-risk populations identifiable (Figure 11) [49, 50]. A key 
characteristic of these risk ‘windows’ is tightly regulated tissue remodeling driven by 
hormonal signaling, as well as mammary epithelium and stromal cross-talk [51, 52]. 
Epidemiological studies have established a connection between life events and breast 
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cancer risk: age at puberty, age at first birth, length of time between menarche and first 
birth, and age at menopause [49]. These ‘windows’ and epidemiological studies led to 
the idea of preventative strategies for cancer prevention at crucial points during 
mammary gland development [49, 50, 53].  While intervention during pubertal 
development would have potential to dramatically reduce breast cancer incidence, 
treating adolescents with chemoprevention drugs is highly controversial, leaving 
preventative strategies such as diet, exercise and other lifestyle modifications [49, 50, 
53].  
   
Pubertal Diet and Breast Cancer Risk. Dietary factors are known to effect 
mammary gland development during puberty, tumor occurrence and progression [12, 37, 
54]. In a BALB/c mouse model, mice were fed a high-fat diet during puberty, followed by 
initiation of tumorigenesis by 7,12-dimethylbenz[a]anthracene (DMBA). It was observed 
that mice fed a high-fat diet, regardless of intervention with low-fat diet during puberty, 
 
Figure 11. Windows of Susceptibility in Development. Schematic of breast 
development, showing ‘windows of risk’. Taken from “Developmental windows of 
breast cancer risk provide opportunities for targeted chemoprevention.” by H. 





showed increased tumorigenesis, with basal-like, triple-negative, adenosquamous 
characteristics. Tumors showed elevated levels of proliferation, macrophages and 
vascularization. Interestingly, these functional characteristics were observed before the 
activation of tumorigenesis in the developing mammary gland [55, 56]. Pubertal diet high 
in n-6 PUFA a component seen in modern Western Diet has shown to lead to changes 
in mammary gland development and mammary gland tumor development [36-39]. 
Studies done in rats have shown that a pubertal diet high in n-3 PUFA also leads to 
increased breast cancer risk, via increased proliferation, lipid peroxidation, DNA damage 
and cyclin D1 expression, as well as reduced apoptosis and BRCA1 expression [36-39].  
 Studies have also shown that pubertal exposure to phytoestrogen, genistein, 
reduces incidence of tumors in animal models, possibly via alteration of 
apoptosis/proliferation, reduction of TEB number, increased epithelial differentiation or 
upregulation of BRCA1 [54]. Rats fed a low-fat n-3 PUFA diet reduced mammary 
tumorigenesis associated with decreased proliferation, increased cell death and 
alteration of gene expression [36-39]. Exposure to 10% Flaxseed and optimal vitamin A 
levels were also shown to reduce breast cancer risk later in life [54]. Studies such as 
these show an important role of dietary exposure during pubertal mammary gland 









Overall Rationale: Increased consumption of processed food, smoking and a sedentary 
lifestyle can lead to the accumulation of AGEs in the body. These reactive sugar 
metabolites are formed as a consequence of sugar metabolism and heat treatment of 
protein rich foods containing sugars and/or lipids. AGE:RAGE signaling has been shown 
to lead to the generation of reactive oxygen species (ROS) and activation of the 
PI3K/Akt and MAPK pathways, ultimately leading to the downstream activation of 
transcription factors NF-κB, hypoxia-inducible factor 1-alpha (Hif1alpha) and signal 
transducer and activator of transcription 3 (Stat3). This activation leads to an increase in 
cytokines, such as IL-6 and IL-1, E-selectin, vascular endothelial growth factor (VEGF), 
vascular cell adhesion protein 1 (VCAM-1), increased immune cell recruitment and 
further AGE production [1-5, 9, 10, 13, 18]. Studies have shown that transgenic mouse 
models leading to a reduction of macrophages in the mammary gland, resulted in the 
reduction of the number of terminal end buds (TEBs), decreased branching and caused 
abnormal TEB morphology. When the mice were treated to recover macrophage 
recruitment to the gland, TEB number and TEB morphology was rescued and ductal 
branching was increased, but not completely restored [19, 26, 28, 29, 31-35, 45]. 
Therefore, we hypothesize that chronic inflammation as a result of AGE:RAGE signaling 
may lead to phenotypic changes in pubertal mammary gland development leading to an 
increase in breast cancer risk. 
Critical events during sensitive stages of development, such as puberty may 
influence the mammary gland microenvironment leading to increased breast cancer risk 
and/or promote tumor growth. Obesity, exercise, time of first child, breast feeding and 
birth control usage are important risk factors of breast cancer risk later in life. Diet and 
other lifestyle factors such as smoking and alcohol consumption have also been shown 
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to lead to increased breast cancer risk. For instance, Asian women typically have a 
lower risk of breast cancer compared to women exposed to Western diet, however within 
one generation of immigration to the United States Asian women have increased breast 
cancer risk, similar to that of women exposed to a Western diet for the majority of their 
lifetime [50, 51, 53, 57, 58]. The increase of AGE presence in the modern world from 
highly processed food and a sedentary lifestyle, with the consequence of its signaling 
through RAGE has led us to investigate its effects on mammary gland pubertal 
development and breast cancer risk in adulthood. 
Hypothesis: We hypothesize that mice fed a high AGE diet will result in dysregulation of 
normal pubertal mammary gland development, leading to an increase in breast cancer 
risk. 
Specific Aim 1: To test the hypothesis that high AGE diet impairs normal pubertal 
mammary gland development. Pubertal mammary gland development is a tightly 
regulated process of cellular communication between stromal and epithelial cells. 
Immune cells such as macrophages and eosinophils play an important role in the 
development of the gland as seen in knockout mouse models. Reduction of immune 
cells leads to alterations of ductal morphogenesis and TEB number in the gland during 
puberty [28, 29]. AGE:RAGE signaling leads to a pro-oxidant and pro-inflammatory 
environment [11]. Transgenic mice with aberrant activation of NF-κB during development 
have shown phenotypic changes of mammary glands associated with increased 
branching and TEB size, possibly from inflammatory factors [15]. NF-κB is a known 
downstream transcription factor of AGE:RAGE signaling [11]. These observed changes 
lead us to develop a model of dietary exposure during pubertal development of high 
AGE to determine the effects these reactive sugar metabolites may cause on pubertal 
mammary gland development. 
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• Task 1: Establish the mouse model for regular, low (endogenous) AGE and high 
(exogenous) AGE diets: 
1) Assess AGE levels in food of mouse diets by Dot Blot and ELISA 
2) Assess circulating AGE levels in dietary mouse models by ELISA 
3) Assess AGE accumulation in mammary gland tissue of dietary mouse 
models by immunohistochemistry 
• Task 2: Evaluate the gross mammary gland phenotype differences among the 
diets in pubertal development using carmine stained whole mounts: 
1) Quantify TEB size  
2) Quantify TEB number  
3) Quantify ductal branching  
4) Quantify ductal extension  
• Task 3: Evaluate the morphological differences of pubertal structures among the 
diets: 
1) Histologically evaluate TEB morphology  
2) Histologically evaluate ductal structures  
3) Histologically evaluate aberrant stromal recruitment surrounding TEBs 
and ductal structures 
• Task 4: Evaluate expression of RAGE and in dietary mouse models  
1) Perform RAGE IHC on mammary gland tissue  
Experimental Design 
AGE Specific Diets. The diets that we utilized in our development model are referred to 
as: regular, low AGE and high AGE. Our control diet or regular diet (TestDiet DIO 58G9) 
consists of 60% k/cal fat. The low AGE diet (TestDiet DIO 58G7), as named by our 
research team, consists of 12% k/cal fat. The experimental diet or high AGE diet is the 
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low AGE diet autoclaved at 120ºC for 15 minutes to promote AGE formation. Additional 
nutritional information of the specific diets is provided in Table 1. Each week a measured 
amount of food was supplied to the mice ad lib and then measured the following week to 
ascertain the amount of food consumed per mouse per week. 
Table 1. Nutritional Information of Control and Experimental Diets 
 Protein % Fat % Fiber % Carbohydrates % 
Regular 24.2 34.7 5.5 27.8 
Low/High AGE* 20.8 23.6 5.8 41.2 
*High AGE is the same as low, but autoclaved at 120ºC for 15 minutes 
 
AGE Dot Blot. AGE content was qualitatively evaluated in the test diets and control 
diets via Dot Blot analysis. Regular food was autoclaved at 120ºC for 15 minutes as 
described above for the experimental diet to compare the AGE formation in control diet 
during autoclave process. Food (1 g) was dissolved in 10 mL of 1x PBS by rotation 
overnight. Carefully 2 µL of dissolved food was applied to a nitrocellulose membrane 
(Fisher Scientific, Fair Lawn, NJ), covered and left to dry at room temperature (RT) for 1 
hour. The membrane was blocked with 5% BSA in 1X TBST for 30 minutes on a shaker 
at RT. Primary antibody for AGE (ab23722; Abcam, Cambridge, MA) was diluted 1:4000 
using 2.5% BSA in 1X TBST and incubated overnight at 4°C on a shaker. The 
membrane was washed 5 times for 10 minutes in 1X TBST on an orbital shaker. 
Secondary anti-rabbit HRP linked antibody (Cell Biolabs, Inc. San Diego, CA) was 
applied to the membrane at a 1:2000 dilution for 2 hours at 4°C on a shaker. The 
membrane was washed 5 times for 10 minutes in 1X TBST on an orbital shaker. Blots 
were then incubated with 2 mL Clarity Western ECL substrate (Pierce, Rockford, IL) for 
5 minutes to activate the signal. Finally, using autoradiography film (Denville Scientific, 
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Metuchen, NJ) blots were developed at a one hour time exposure with an automatic 
developer (Kodak, Rochester, NY). 
AGE ELISA. AGE concentration was quantitatively evaluated in the experimental and 
control diets using the OxiSelect™ Advanced Glycation End-Product (AGE) Competitive 
ELISA Kit (Cell Biolabs, Inc. San Diego, CA). AGE Conjugate solution was prepared, 
100 µL added to each well of the 96 well-plate and incubated overnight at 4ºC. The 
solution was removed and washed twice with 1X PBS, 200 µL of Assay Diluent was 
added to each well and blocked for 1 hour at RT, and stored at 4ºC. A series of AGE-
BSA standards was prepared, ranging from 1.56 µg/mL to 100 µg/mL. Food solutions 
were prepared by dissolving 1 g of each diet in 1x PBS. Assay Diluent was removed, 
and 50 µL of each unknown sample and standard was assayed in duplication on the 
AGE Conjugate coated plate. The plate was incubated at RT for 10 minutes on an orbital 
shaker. Anti-AGE Antibody (Cell Biolabs, Inc.) was diluted 1:1000 and 50 uL added to 
each well and incubated at RT on an orbital shaker for 1 hour. Wells were washed 3X 
times with 250 µL 1X Wash Buffer (Cell Biolabs, Inc.) with thorough aspirations in-
between. Excess 1X Wash Buffer was removed and 100 µL of 1:1000 Secondary 
Antibody-Horseradish Peroxidase (HRP) Conjugate (Cell Biolabs, Inc.) was added to all 
wells and incubated for 1 hour on an orbital shaker at RT. Wells were washed 3X times 
with 250 µL 1X Wash Buffer. Substrate Solution (Cell Biolabs,) was warmed to room 
temperature and 100 µL was added to each well, watching carefully for color change in 
samples. Reaction was stopped when change in color was observed by adding 100 µL 
of Stop Solution (Cell Biolabs, Inc.). Results were read immediately on microplate reader 
(Bio-Tek Instruments, Inc. Winooski, VT) at 450 nm. 
Development of Mouse Model. Dietary Mouse Model. Female wild-type FVB/n mice 
were weaned at 3 weeks of age, a baseline blood sample was collected via cardiac 
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puncture from a sub-set group. Specific diets were started at weaning; high AGE, low 
AGE and regular. Each week the weight of each mouse was recorded and analyzed for 
longitudinal analysis, as was food consumption. Diets continued till desired endpoints of 
7, 8 (pubertal) and 12 weeks (mature virgin). At these endpoints, mammary glands were 
extracted from the mice for whole mounting and paraffin embedding, focusing on the 
inguinal gland, utilizing the lymph node as a geographical marker for analysis. Tissue 
was also collected and fresh frozen for future protein and RNA extraction. Blood was 
collected at each end-point via cardiac puncture (Figure 12). 
 
Evaluation of Circulating AGEs. Endpoint blood samples were centrifuged at 6,000 
RPM for 20 minutes to separate and isolate serum and stored at -80ºC. Samples from 
weaning and end-points (7, 8, and 12 weeks) were compared using Dot Blot analysis (as 
described above) to determine differences in circulating AGE levels before and after diet. 
Serum samples were diluted 1:20 and followed the previous mentioned protocol with a 5 
second exposure time. Samples were also evaluated for circulating AGE concentration 
using OxiSelect™ Advanced Glycation End-Product (AGE) Competitive ELISA Kit (Cell 
Biolabs, Inc.), as described above. 
Whole Mounts and Analysis. Extracted mammary glands were stretched onto a glass 
slide and fixed in 4% paraformaldehyde (PFA) at 4ºC overnight, followed by a series of 
washes to rehydrate the tissue: 1X 70% ethanol (EtOH), 1X 50% EtOH, 1X 30% EtOH 
 
Figure 12. Timeline of Dietary Mouse Model. 
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and autoclaved water for 1 hour each at RT. Tissue was then immersed in carmine 
staining solution (0.2% carmine, 0.5% aluminum potassium sulfate (Sigma-Aldrich Co., 
St. Louis, MO)) overnight at RT, followed by a series of washes to dehydrate the tissue: 
autoclaved water, 1X 30% EtOH, 1X 50% EtOH, 1X 70% EtOH,; 2X 95% EtOH, 2X 
100% EtOH for 1 hour each. Glands were then covered with a clean slide and clipped 
together and immersed in xylene overnight. Glass cover slips were then mounted on top 
of slides using Permount® (Fisher Scientific, Fair Lawn, NJ). Once dry, the whole 
mounts were photographed using a photo scanner (Epson Perfection 2450 Photo).  
TEB Area was assessed using ImageJ software and the scans of the inguinal 
glands. TEBs were identified as club-like structures at the end of branches and 
predominantly in the leading edge of the developing gland. After setting the scale, length 
(from tip to neck) and width (at the widest point) of the TEB was assessed as illustrated 
in Figure 13 A. The collected measurements were then placed into the formula for the 
area of an ellipse (πab) to calculate the area of the TEB. Average area was compared 
between individual mice and among the diets. 
TEB Number was assessed using ImageJ software and the scans of the inguinal 
glands. A field of view 2 mm2 was established and placed at the top edge of the gland 
with the leading edge centered. Once the number of TEBs was calculated per field, the 
field was moved down the gland till the entire gland was covered and counted (Figure 13 
B). Average number of TEBs per field of view was compared between individual mice 




Ductal Branching was assessed using ImageJ software and the scans of the 
inguinal glands. A field of view 2 mm2 was established and placed at the top edge of the 
gland with the leading edge to the far-right side of the field. The field was then moved 2 
fields back into the ductal tree of the gland. Primary (1º), secondary (2º) and tertiary (3º) 
branchpoints were counted as seen in Figure 14. Once all branchpoints per field were 
counted, the field was moved down the gland till the entire gland was covered and 
counted. Total branching was calculated by summing all branchpoints per field of view. 




Figure 13. Schematic of TEB Size and TEB Number Analysis. (A) TEBs were 
measured at the widest point and from neck to tip to obtain the area using the 
formula for an ellipse. (B) TEB number, using inguinal whole mounts was analyzed 









Ductal Extension was assessed using 
ImageJ software and the scans of the inguinal 
glands. After setting the scale, length from the 
end of the lymph node to the tip of the furthest 
TEB in the leading edge was measured 
(Figure 15). Average ductal extension was 
compared among the diets. 
Paraffin Embedding. After extraction, mammary glands were placed into 4% PFA at 
4ºC overnight. Followed by a series of washes to dehydrate the tissue: 1X 70% EtOH for 
1 hour; 2X 95% EtOH, 2X 100% EtOH for 1 hour each; toluene for 1-4 hours. Glands 
were then placed in 50/50 mix toluene/paraffin at 60ºC overnight. The following day, 
glands were incubated in paraffin 2 times for 2 hours each at 60ºC. Finally, glands were 
embedded in paraffin dorsal side down. 
 
Figure 14. Schematic of Ductal Branching Analysis. (A) Schematic for the 
analysis of ductal branching using inguinal whole mounts. (B) Demonstration of 










Figure 15. Schematic of Ductal 
Extension Analysis. Measurements 
were made from the lymph node 







AGE/RAGE IHC. In order to assess AGE localization and RAGE presence in the 
mammary gland, paraffin embedded inguinal mammary glands were sliced 5 µm thick 
and utilized for IHC. Slides were deparaffinized at 60º C for 1 hour. Followed by a series 
of washes to rehydrate the tissue: 2X xylene for 20 minutes each; air dry for 15 minutes; 
3X 100% EtOH, 2X 95% EtOH, 1X 70% EtOH, and 1X 50% EtOH for 10 minutes each; 
3X diH20 for 5 minutes each. For antigen retrieval Vector unmasking solution (Vector 
Labs, Burlingame, CA) was used at a 1:100 dilution. Slides were placed in a pap jar 
containing the diluted unmasking solution, brought to boiling and placed in a vegetable 
steamer containing the diluted solution, for 30 minutes at 90°C. The slides were then 
placed in a pap jar containing 0.3% hydrogen peroxide (Fisher Scientific, Fair Lawn, NJ) 
for 30 minutes to remove any endogenous peroxidase, then washed in 1X phosphate-
buffered saline containing 0.01% Tween-20 (PBST) (Fisher Scientific, Fair Lawn, NJ) for 
5 minutes. Slides were then incubated in VECTASTAIN® horse serum (Vector Labs, 
Burlingame, CA) to block non-specific binding for 20 minutes at RT in a humidified 
chamber. Primary antibody (Abcam, Cambridge, MA) was diluted using 2.5% horse 
blocking serum diluted with 1X PBS and applied to slides to incubate overnight at 4°C in 
a humidified chamber (Table 2.). Primary antibody was then removed by washing 3 
times in 1X PBS for 5 minutes on an orbital shaker. Followed by incubation with 
VECTASTAIN® secondary antibody solution (Vector Labs, Burlingame, CA) for 30 
minutes at RT in a humidified chamber. Slides were washed again 3 times in 1X PBS for 
5 minutes on an orbital shaker. Samples were then incubated with SIGMAFASTTM DAB 
(Sigma-Aldrich Co., St. Louis, MO) to activate the signal, then placed in diH20 3 times for 
5 minutes to stop enzymatic reaction. Hematoxylin (Fisher Scientific, Fair Lawn, NJ) was 
placed on the tissue and placed into diH20. Followed by a series of washes to complete 
the counter stain: HCl-EtOH for 90 seconds; NH4OH-EtOH for 45 seconds; diH20 for 3 
minutes; Scott’s Buffer for 1 minute. Stained slides were then dehydrated by a series of 
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washes: 3-diH20 for three minutes each; 1X 50% EtOH, 1X 70% EtOH, 2X 95% EtOH, 
and 3X 100% EtOH for 5 minutes each; air dry for 15 minutes; 2X xylene for 10 minutes 
each. Glass cover slips were then mounted on top of slides using Permount® (Fisher 
Scientific, Fair Lawn, NJ). Imaging was completed using an Olympus DP80 microscope 
(Olympus American, Inc. Center Valley, PA). 
Table 2. Antibody Information for Specific Aim 1 IHC Methodology 
 Ab Number Dilution Secondary Ab DAB Hematoxylin 
AGE ab23722 1:50 Rabbit 30 sec 1 min 
RAGE ab37647 1:50 Rabbit 30 sec 1 min 
 
H&E. In order to assess morphological changes in mammary glands among diets, 
paraffin embedded inguinal tissue was sliced 5 µm thick and utilized for H&E. Slides 
were deparaffinized at 60º C for 1 hour. Followed by a series of washes to rehydrate the 
tissue: 3X xylene, 3X 100% EtOH, 1X 95% EtOH, 1X 80% EtOH for 3 minutes each; 
diH20 for 5 minutes. Samples were then covered with Hematoxylin (Fisher Scientific, Fair 
Lawn, NJ) for 3 minutes and rinsed in diH20. Slides then followed a series of washes: tap 
water for 5 minutes; HCl-EtOH 8-12 dips; 2-tap H20 for 1 minute; diH20 for 2 minutes. 
Tissue was then covered by Eosin (Fisher Scientific, Fair Lawn, NJ) for 30 seconds. 
Followed by a series of washes to dehydrate the tissue: 3X 95% EtOH, 3X 100% EtOH 
for 5 minutes each, 3X xylene for 15 minutes each. Glass cover slips were then mounted 
on top of slides using Permount® (Fisher Scientific, Fair Lawn, NJ). Imaging was 






 High AGE food is an exogenous source of AGEs, low AGE food is an endogenous 
source of AGEs. In order to determine AGE content in the experimental diets, we 
utilized ELISA and Dot Blot analysis. The high AGE diet contained a significant amount 
of pre-formed AGEs from the 
autoclaving process when 
compared to low AGE and 
control diets (Figure 16). By 
dot blot analysis, the regular 
diet showed no detectable 
pre-formed AGEs, even when 
autoclaved in the same 
manner as high AGE food 
(Figure 16 B). Low AGE while 
containing some pre-formed 
AGEs still contains the 
building blocks for AGE 
formation, i.e. increased sugar content (Table 1), therefore we predict that we may 
observe changes in mammary gland development with the low AGE diet when 
compared to the regular diet, but not as severe as those observed in mice fed the high 
AGE diet. 
High AGE and low AGE diet lead to an increase in circulating AGEs. To assess the 
amount of circulating AGEs in mice fed the regular and experimental diets we utilized 
ELISA analysis. High AGE saw an increase in circulating AGE levels compared to 
regular and pre-draw, low AGE saw an increase in circulating AGE levels compared to 
 
Figure 16. AGE Content in Mice Diets. ELISA (A) 
and Dot Blot analysis (B) for AGE content in diets 
used in our model reveal significant amount of pre-




baseline levels, further supporting the idea of exogenous and endogenous AGEs (Figure 
17). In all three endpoints both diets showed to have more circulating AGEs compared to 
regular diet fed mice. 
 
Diets did not result in significant changes in weight or food consumption. We 
monitored weight gain and food consumption among the diets, as obesity and over 
consumption of diets caused by enhanced taste may lead to changes in development 
and AGE content in the mice. Each week food consumption and weight was monitored 
to assess changes. The weight of the mice showed there was no overall significant 
difference among the diets (Figure 18 A). Monitoring these variables was important to 
ensure that any effects observed were not caused by external factors such as obesity, 
as obesity has been shown to lead to changes in development and increase in breast 
cancer risk [52, 54]. Food consumption was monitored to assure that mice were not 
consuming more of one diet compared to another, leading to a more dramatic 
 
Figure 17. Pubertal Circulating AGE Levels in Mice. Circulating AGE levels 
evaluated via ELISA revealed significant increase of AGEs in the high AGE fed 








































phenotype. Food consumption, while showing fluctuations from week to week, showed 
no overall significant difference among the models (Figure 18 B). 
 
High AGE diet resulted in increased TEB size and number in mice during pubertal 
development. Macroscopically looking at whole mounts of High AGE diet we observed 
increased TEB size and number compared to other glands. This same phenotype was 
observed in transgenic mice with aberrant NF-κB activation, a known downstream target 
of AGE:RAGE signaling [15]. This observation prompted us to quantify changes in TEB 
size and number during pubertal development and adulthood using whole mounted 
inguinal mammary glands. The results show that mice fed a high AGE diet had a 
significant increase in TEB area compared to low AGE (7 weeks) and regular diets (7 & 
 
Figure 18. Mice Weight and Food Consumption. Longitudinal analysis shows 
there is no significant difference in weight (A) and food consumption (B) per mouse 






8 weeks). Interestingly, low AGE also showed an increase in TEB area compared to 
regular diet at week 7 (Figure 19 A). Increased number of TEBs was also seen at both 7 
and 8 weeks using carmine stained glands of mice fed the high AGE diet compared to 
regular diet (Figure 19 B). This observation was carried into adulthood as presence of 
TEBs was seen in both the high and low AGE diets, a time point where TEBs are 




Figure 19. TEB Area and Number Among Diets. Carmine stained whole mount 
analysis revealed that a diet high in AGEs resulted in increased TEB area (A) as well 
as number (B) per field of view.  
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Table 3. Number of Inguinal Glands that Contained TEBs at Adulthood per Diet. 
 Regular Low AGE High AGE 
Glands with TEBs 2 5 4 
Total Glands 4 5 4 
Percent (%) 50% 100% 100% 
 
Mice fed a high AGE diet resulted in increased ductal branching. Macroscopically 
looking at whole mounts of high AGE diet we observed what looked to be increased 
thickness of the ductal tree compared to other glands. This was a phenotype also 
caused by increased branching in transgenic mice with aberrant NF-κB activation, a 
known activated transcription factor of AGE:RAGE signaling [15]. This observation 
prompted us to quantify changes in ductal branching during pubertal development and 
adulthood utilizing whole mounted inguinal mammary glands. We observed that mice fed 
a high AGE diet showed significant increase in total ductal branching per field of view at 
7, 8 and 12 weeks (Figure 20 A). Looking specifically at branchpoints in these glands, 
we see that at 8 and 12 weeks a diet high in AGEs leads to increased primary branches 
per field of view compared to regular and low AGE diets (Figure 20 B). Secondary and 







Ductal extension was delayed in mice fed a high AGE diet and recovered at 
adulthood. Macroscopic examination of high AGE diet whole mounts showed a 
decrease of ductal tree extension into the mammary fat pad compared to other inguinal 
mammary glands. This observation prompted us to quantify changes in ductal extension 
during pubertal development and adulthood by utilizing whole mount inguinal glands. We 
observed a significant reduction of ductal extension in mice fed a high AGE diet during 





Figure 20. Ductal Branching Among Diets. Carmine stained whole mount analysis 
revealed that a diet high in AGEs resulted in increased total ductal branching (A) per 
field of view, mostly as a result from increased primary branching (B) per field of 
view. No significant difference was observed among secondary (C) and tertiary 
branching (D). 
 























TEB and duct morphology was disorganized in mice fed a high AGE diet.           
The increased size of TEBs led us to 
propose that the high AGE diet may cause 
morphological changes in pubertal 
structures. In order to assess these 
changes in TEB and duct morphology we 
utilized H&E analysis of pubertal time 
points using inguinal mammary glands. 
Histological analysis of H&E stained glands 
showed a disorganization in TEB 
morphology from their normal club-like 
structures, mice fed a high AGE and low 
AGE diet showed a thickening of TEB 
 
Figure 21. Ductal Extension Among Diets. Carmine stained whole mount analysis 
revealed that a diet high in AGEs resulted in a delay in ductal extension during 
puberty which recovered in adulthood.  





Figure 22. Morphological Changes of 
TEBs. Representative H&E stained glands 
showed that high/low AGE diet TEBs were 
surrounded by a thicker more cellular 
stroma compared to regular. Consisting of 





epithelial at the tail and reduced cellular presence at the tip. The diets also resulted in 
changes in stroma surrounding the TEBs. Normal TEB stromal surrounds the neck of the 
TEB, in mice fed a high/low AGE diet increased stroma was localized around the entire 
structure and appears thicker and more cellular. We had our collaborating veterinarian 
pathologist (Dr. Kristi Helke) examine the stroma surrounding the TEBs and confirmed 
by morphological analysis that the predominant cell type recruited to the abnormal 
stroma to be macrophages and fibroblasts (Figure 22). H&E stained mammary glands 
showed that both diets also resulted in a thickening of ducts from their normal epithelial 
mono-layer to multi-layered structures with a thickening stroma, as seen around the 
TEBs (Figure 23). Ducts of both high and low AGE diet also demonstrated sloughing of 
the epithelial cells into the lumen during puberty and adulthood compared to regular diet 
(Figure 23 C). 
 
High AGE diet led to increased RAGE and AGE presence in the developing gland. 
A result of AGE:RAGE signaling is a positive feedback loop leading to increased RAGE 
expression prompting us to assess changes in RAGE and tissue specific AGE presence 
 
Figure 23. Morphological Changes of Ducts. Representative H&E stained glands 
showed that high (B) and low AGE ducts were multi-cellular and surrounded by a 
thicker more cellular stroma compared to regular (A). High (C) and low AGE ducts 






of structures during pubertal development via IHC analysis using inguinal glands. 
Regular diet mice TEBs and ducts epithelial cells stained positive for RAGE, when the 
mice were subjected to high and low AGE diets an upregulation of positively stained 
epithelial cells in these structures were observed (Figure 24). Little to no positive stained 
adipocytes and stromal cells were observed in regular diet mice, when a pubertal high 
AGE diet was sustained, increased RAGE staining was observed in cells surrounding 
TEBs and ducts, suspected to be macrophages (Figure 24). 
 
Regular diet mice inguinal mammary glands were stained for tissue specific 
AGEs, showing little to no positive stain in the gland, except for inside the lumen of the 
ducts. Mice fed a high AGE diet showed increase staining in the epithelial cells of TEBs 
 
Figure 24. Pubertal Structures RAGE IHC. Representative RAGE IHC stains 
showing the upregulation of RAGE in adipocytes, epithelial, and stromal cells, 
believed to be macrophages (arrows) in pubertal structures of mice fed a high age 






and ducts during development, as well as the surrounding stroma. Increased AGE 
staining was also seen inside the lumen of the structures and the adipocytes of the 
glands (Figure 25).  Low AGE diet showed moderate staining of epithelial, fat and 
stroma cells similar to high AGE. 
 
Discussion and Alternative Approaches 
 In this aim, we showed that mice fed a diet high in AGEs leads to significant 
changes in pubertal mammary gland development. Monitoring food consumption and 
weight gain of the mice fed our experimental and control diets allowed us to limit the 
variability of obesity or over eating to cause the observed changes. Analysis of our diets 
 
Figure 25. Pubertal Structures AGE IHC.  Representative AGE IHC stains, showing 
presence of AGE in adipocytes, epithelial, and stromal cells in pubertal structures of 
mice fed a high age diet, sustaining into adulthood. 
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showed increased exogenous AGEs in the cooked high AGE food, low AGE showed 
moderate AGE content, but still contained the precursors for AGE formation. Evaluation 
of circulating AGEs in serum and tissue specific AGEs in glands of the mice showed 
high levels of AGE in mice fed the high AGE diet, as well as moderate levels of AGE in 
the low AGE diet compared to regular. This led us to believe the low AGE diet was 
acting as a source of endogenous AGEs as normal metabolism may be leading to the 
formation of AGEs from the precursors of the diet [1, 2, 4]. This in part explained the 
trend towards the high AGE diet phenotypic changes observed in the mice fed a low 
AGE diet. Suggesting the low AGE diet was able to mediate some of the effects 
observed in the mice fed a high AGE diet, but to in some cases a less significant 
manner. This was later enforced when we observed increased RAGE expression in the 
glands of high/low AGE mice compared to regular, showing a possible positive feed-
forward loop of RAGE expression via AGE:RAGE signaling [11].  
 TEBs a characteristic structure of pubertal mammary gland development were 
significantly affected by a diet high in AGEs, including increased TEB size and number. 
This may be as a resultant of pro-inflammatory signaling via AGE:RAGE leading to 
increased activation of fibroblasts and recruitment of macrophages but this remains to 
be confirmed. Knockout mouse models of mammary gland development have shown 
these stromal cells to be important in the development and management of TEBs, 
especially macrophages which when removed lead to a decrease in TEB number and 
TEB size, opposite of what we observed [11, 28, 29]. Interestingly, increased TEB 
presence sustained into adulthood, which is a time of quiescence, these structures are 
similar to terminal ductal lobular unit 1 (TDLU1) known to be the main initiation site of 
human breast cancer, possibly increasing breast cancer incidence by having these 
structures still present. TEB size may have also been affected by increased macrophage 
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recruitment as macrophages are known to secrete factors to promote proliferation, 
possibly leading to an increase in size [15, 26, 33, 44]. This increased proliferation may 
explain the thickening of the TEBs and ducts observed in H&E of high AGE mice. 
 Interestingly, reduction of macrophages in knockout models also resulted in a 
reduction of ductal branching, where we observed an increase with pubertal high AGE 
diet, possibly via the increased recruitment of macrophages (which we observed via 
H&E and later in Specific Aim 2). The main ductal branch-point increased in the high 
AGE diet inguinal mammary glands was primary branch-points, which are formed from 
the bifurcation of TEBs, increased TEBs which we observed may be the underlying 
factor of increased primary and total ductal branching. This increase of TEB bifurcation 
and primary ductal branching may also explain the delayed ductal extension observed in 
the high AGE fed mice. Increased bifurcation leads to deflection off the TEBs path to fill 
the fat pad, this more tortuous path causes an observed delay in extension as the ductal 
tree will fill the fat pad to fulfill the glands function, but will take longer to achieve. The 
observed ductal extension delay may also be a cause of change to collagen presence in 
the ECM as TEBs utilize collagen 1 in the direction of their forward path to fill the gland, 
activated fibroblasts, macrophage recruitment and direct AGE cross-linking to collagen 
may affect the path of the TEBs delaying extension [21, 22, 24, 59]. 
 Taken together, this data suggests that a pubertal diet high in AGEs leads to a 
significant disruption of pubertal mammary gland development, which we believe to be a 
result of pro-inflammatory signaling via AGE:RAGE signaling leading to increased 
macrophage and fibroblasts recruitment to pubertal structures of development. These 
changes to development may lead to effects of breast cancer risk which we further 
investigate in Specific Aim 2. 
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 A caveat of our experimental design in this specific aim is the non-fasting of 
animals before collection of blood from cardiac puncture and not properly synching the 
estrous cycles of the models. Animals may have consumed food before being collected, 
this may skew the AGE levels of the serum when analyzed showing a false increase of 
AGE content. Using development models, specifically pubertal models, it is suggested to 
synch estrous cycles of animals. This synching decreases the variability in the timing of 
development as one animal could be further into or behind development compared to 
another. Future directions for this aim would be to carry out serum collection during 















Specific Aim 2: To test the hypothesis that high AGE diet will lead to the formation 
of pre-neoplastic lesions in adulthood. Pubertal mammary gland development is a 
tightly regulated process of cellular communication between stromal and epithelial cells. 
Immune cells such as macrophages play any important role in the development process 
[28, 29]. AGE:RAGE signaling leads to a pro-oxidant and pro-inflammatory environment, 
which we see leads to a dysregulation of pubertal mammary gland development. 
Interestingly, aberrant activation of NF-κB by transgenic mouse model showed that this 
known downstream factor of AGE:RAGE signaling, led to the formation of DCIS like 
structures, possibly by increased and sustained immune response via its activation [15]. 
These observed changes caused by AGEs during pubertal development lead us to 
determine if the effects of these reactive sugar metabolites may cause the development 
of pre-neoplastic lesions as result of AGE:RAGE signaling. 
• Task 1: Evaluate the presence of pre-neoplastic lesions among the diets via 
H&E: 
1) Quantify the presence of ADH and MIN structures in pubertal and adult 
glands  
• Task 2: Evaluate proliferation among the diets via Ki67 IHC: 
1) Perform Ki67 IHC on slices from pubertal and adult glands  
2) Quantify proliferation of ducts, TEBs and pre-neoplastic lesions 
• Task 3: Evaluate aberrant morphology of TEBs, ductal structures and pre-
neoplastic lesions: 
1) Perform IHC with aSMA to assess myoepithelial organization and 
fibroblast activation in stroma 





H&E. H&E techniques from Specific Aim 1 were utilized to assess the formation of pre-
neoplastic lesions of pubertal and adult inguinal mammary glands. 
RAGE/AGE IHC. IHC techniques from Specific Aim 1 were utilized to assess changes in 
RAGE and AGE presence in pre-neoplastic lesions of pubertal and adult inguinal 
mammary glands.  
Ki67/SMA IHC. IHC techniques were used to assess proliferation, myoepithelial 
structure and fibroblast activation and macrophage presence in the mammary gland. 
Paraffin embedded inguinal tissue was sliced 5 µm thick and utilized for IHC. Slides 
were deparaffinized at 60º C for 1 hour. Followed by a series of washes to rehydrate the 
tissue: 2X xylene for 20 minutes each; air dry for 15 minutes; 3X 100% EtOH, 2X 95% 
EtOH, 1X 70% EtOH, and 1X 50% EtOH for 10 minutes each; 3X diH20 for 5 minutes 
each. For antigen retrieval Vector unmasking solution (Vector Labs, Burlingame, CA) 
was used at a 1:100 dilution. Slides were placed in a pap jar containing the diluted 
unmasking solution, brought to boiling and placed in a vegetable steamer containing the 
diluted solution, for 30 minutes at 90°C. The slides were then placed in a pap jar 
containing 0.3% hydrogen peroxide (Fisher Scientific, Fair Lawn, NJ) for 30 minutes to 
remove any endogenous peroxidase, then washed in 1X phosphate-buffered saline 
containing 0.01% Tween-20 (PBST) (Fisher Scientific, Fair Lawn, NJ) for 5 minutes. 
Slides were then incubated in VECTASTAIN® horse serum (Vector Labs, Burlingame, 
CA) to block non-specific binding for 20 minutes at RT in a humidified chamber. Primary 
antibody was diluted using 2.5% horse blocking serum diluted with 1X PBS and applied 
to slides to incubate overnight at 4°C in a humidified chamber (Table 4.). Primary 
antibody (Thermo Fisher Scientific, Waltham, MA) was then removed by washing 3 
times in 1X PBS for 5 minutes on an orbital shaker. Followed by incubation with 
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VECTASTAIN® secondary antibody solution (Vector Labs, Burlingame, CA) for 30 
minutes at RT in a humidified chamber. Slides were washed again 3 times in 1X PBS for 
5 minutes on an orbital shaker. Samples were then incubated with SIGMAFASTTM DAB 
(Sigma-Aldrich Co., St. Louis, MO) to activate the signal, then placed in diH20 3 times for 
5 minutes to stop enzymatic reaction. Hematoxylin (Fisher Scientific, Fair Lawn, NJ) was 
placed on the tissue and placed into diH20. Followed by a series of washes to complete 
the counter stain: HCL-EtOH for 90 seconds; NH4OH-EtOH for 45 seconds; diH20 for 3 
minutes; Scott’s Buffer for 1 minute. Stained slides were then dehydrated by a series of 
washes: 3-diH20 for three minutes each; 1X 50% EtOH, 1X 70% EtOH, 2X 95% EtOH, 
and 3X 100% EtOH for 5 minutes each; air dry for 15 minutes; 2X xylene for 10 minutes 
each. Glass cover slips were then mounted on top of slides using Permount® (Fisher 
Scientific, Fair Lawn, NJ). Imaging was completed using an Olympus DP80 microscope 
(Olympus American, Inc. Center Valley, PA). 
 
Ki67 Quantification. Images were analyzed using ImageJ software by counting positive 
or brown stained cells of pubertal structures and pre-neoplastic lesions. Non-positive 
stained cells were counted and totaled to determine the percent positive of each 
structure, which were then averaged for each endpoint. Hyperproliferative ducts were 
ductal structures shown to be over 50% positive (as established by our research team), 
the presence of these structures was analyzed for each endpoint. 
Table 4. Antibody Information for Specific Aim 2 IHC Methodology 
 Ab Number Dilution Secondary Ab DAB Hematoxylin 
Ki67 RM-9106 1:200 Rabbit 5 min 3 min 
SMA PA5-18292 1:100 Goat 15 sec 1 min 
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F4/80 IHC. In order to assess macrophage localization to the TEBs, ducts and pre-
neoplastic lesions in the developing and adult mammary gland, paraffin embedded 
inguinal tissue was sliced 5 µm thick and utilized for IHC. Tissue was stained thanks to 
the Hollings Cancer Center Biorepository and Tissue Analysis shared resource. Primary 
antibody for F4/80 (14-4801-82, Thermo Fisher Scientific, Waltham, MA) was utilized by 
the shared resource to complete the stain. Imaging was completed using an Olympus 
DP80 microscope (Olympus American, Inc. Center Valley, PA). 
Results  
High AGE and Low AGE diet lead to the formation of pre-neoplastic lesions during 
late puberty which are, sustained into adulthood. While looking for morphological 
changes of pubertal structures in H&E stained mammary glands, we observed the 
formation of potential early stage pre-neoplastic lesions during puberty, as well as late 
stage in adult mammary glands. This prompted us to look further into the formation of 
pre-neoplastic lesions during puberty and adulthood of inguinal glands. We observed 
early stage atypical ductal hyperplasia (ADH) in high AGE and low AGE diet during 
puberty (Figure 27 & 29), as well as mammary intraepithelial neoplasia (MIN), which 
sustained into adulthood in both diets (Figure 28 & 29). These structures were 
structurally similar to DCIS that is seen in human breast cancer; thickening of the 
epithelial, increased stromal (containing macrophages and activated fibroblasts), 
hyperproliferation and disorganization of structure caused by disruption of the 







Figure 26. High/Low AGE Diet Leads to Formation of Pre-Neoplastic Lesions. 
(A) In normal breast tissue, stromal cells, including macrophages and fibroblasts are 
present within the ECM. (B) In DCIS, the lumen contains proliferating carcinoma cells 
and the wall of the duct is irregular. Increased recruitment of fibroblasts and 
macrophages is observed in the ECM. Figure adapted from (28). Representative 




Figure 27. Pubertal Pre-Neoplastic Lesions. Representative images of H&E 
stained mammary gland tissue sections from 8 week old mice fed a high AGE diet. 
(A) Atypical epithelia structures representing early stage, low grade atypical ductal 
hyperplasia (ADH). (B) Atypical lesions progress to high grade mammary 
intraepithelial neoplasia (MIN). These larger intraepithelial neoplastic lesions fill the 
ductal lumen but do not invade the basement membrane. These lesions appear 







Figure 28. Adulthood Pre-Neoplastic Lesions. Representative images of H&E 
stained mammary gland tissue sections from wild type mice fed a high AGE diet. (A 
& B) Atypical epithelia structures representing early stage, low grade ADH. (C & D) 
Atypical lesions progress to high grade MIN. These larger intraepithelial neoplastic 
lesions fill the ductal lumen but do not invade the basement membrane. These 
lesions appear similar to human DCIS. 
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Figure 29. Amount of Pre-Neoplastic Lesions. Total number of pre-neoplastic 
lesions during late puberty and adulthood in the inguinal mammary glands of mice 




Pre-neoplastic lesions showed increased presence of RAGE and AGE. As stated 
previously, AGE:RAGE signaling  leads to a positive feedback loop leading to increased 
RAGE expression prompting us to assess changes in RAGE and tissue specific AGE 
presence of pre-neoplastic structures via IHC analysis using inguinal glands. The pre-
neoplastic lesions observed in the high/low AGE diets at puberty and adulthood showed 
increased RAGE expression in the epithelial cells and stromal cells, as well as the 
surrounding adipocytes (Figure 30). The pre-neoplastic lesions were also shown to have 
positive AGE staining in the epithelial and stromal cells of pubertal and adult mice glands 




Figure 30. Pre-Neoplastic RAGE IHC. Representative RAGE IHC stains, showing 
increased presence of RAGE in pre-neoplastic lesions in ADH (A) and MIN (B) 






High AGE diet results in increased proliferation in TEBs and ducts during puberty, 
as well as pre-neoplastic lesions. Increased TEB size, morphological changes and the 
formation of pre-neoplastic lesions prompted us to assess the changes in proliferation of 
pubertal structures and pre-neoplastic lesions during pubertal development and 
adulthood among the diets via Ki67 IHC analysis of inguinal glands. Using Ki67 to 
assess cellular proliferation during puberty, a diet high in AGEs lead to increased 
proliferation of TEBs and ducts during pubertal time points (Figure 32). The diet also 
lead to increased presence of hyper-proliferative ducts in the developing glands, or ducts 
(defined as being over 50% positive for Ki67 staining) (Table 5). It was observed that 
high AGE diet lead to formation of ADH and MIN structures, these structures were highly 
present in high AGE compared to both low AGE and regular diet, which contained no 
such structures (Figure 29). Proliferation was assessed for each structure and showed 
them to be highly proliferative, even into adult hood, normally a time of quiescence 
(Figure 33). 
 
Figure 31. Pre-Neoplastic Lesions AGE IHC. Representative AGE IHC stains, 
showing increased presence of AGE in pre-neoplastic lesions of high AGE (A) and 







Figure 32. TEB and Duct Proliferation. Ki67 IHC showed increased proliferation of 













Table 5. Percentage of Glands Containing Hyperproliferative Ducts 
 Regular Low AGE High AGE 
7 Week 25% 25% 60% 
8 Week 0% 33% 100% 
 
Figure 33. Pre-Neoplastic Lesion Proliferation. Ki67 IHC showed proliferation of 






High AGE diet results in the disruption of the myoepithelial layer in developing 
structures as well as pre-neoplastic lesions. We also observed disruption of structure 
and migration of cells into the fat pad, prompting us to examine the myoepithelial layer 
via SMA IHC of inguinal glands. High AGE diet resulted in disruption of the myoepithelial 
layer in TEBs and ducts of the developing glands (Figure 34). When looking at ADH and 
MIN structures in the pubertal and adult glands fed the experimental diets, disruption of 
the myoepithelial layer was observed in these pre-neoplastic lesions, (Figure 35) a 




Figure 34. Pubertal Structures SMA IHC. Representative image of SMA IHC 
stained mammary gland tissue sections from wild type mice fed a regular and high 
AGE diet. High AGE diet showed disruption of the myoepithelial layer in TEBs and 
ducts of the developing pubertal glands. High AGE diet also showed increased 








High AGE diet results in the increased activation of fibroblasts and macrophage 
recruitment surrounding developing structures and pre-neoplastic lesions. 
Morphological analysis showed increased fibroblasts presence around pubertal 
structures and pre-neoplastic lesions. SMA is a common marker of fibroblasts activation, 
while staining with SMA for disruptions in the myoepithelial layer, it was observed that 
the high AGE diet resulted in an increase in activated fibroblasts recruited to developing 
structures during puberty (Figure 34 insert). In adulthood, high AGE diet showed to 
increase activated fibroblast recruitment surrounding the pre-neoplastic lesions observed 
(Figure 35 insert).  
Morphological analysis also showed that there was increased recruitment of 
macrophages to developing structures and pre-neoplastic lesions of the gland. 
AGE:RAGE signaling is known to lead to a pro-inflammatory response, and immune 
cells are known to play an important role in development, pushing us to further look at 
 
Figure 35. Pre-Neoplastic Lesions SMA IHC. Representative image of SMA IHC 
stained mammary gland tissue sections from wild type mice fed a high AGE diet. High 
AGE diet showed disruption of the myoepithelial layer in pre-neoplastic lesions of the 
pubertal and adult glands. High AGE diet also showed increased activated fibroblasts 
surrounding pre-neoplastic lesions of the adult glands (arrows). 
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macrophage presence by F4/80 IHC. High AGE diet resulted in increased macrophage 
recruitment around developing structures during puberty compared to control diet 
(Figure 36 i & ii). The increased recruitment sustained into adulthood and showed to be 
prevalent around and inside pre-neoplastic lesions of the mice fed high AGE (Figure 36 
iii). Increased macrophage recruitment and activated fibroblasts is a common 
characteristic of DCIS [31, 43]. 
 
Discussion and Alternative Approaches 
 During late pubertal development, it was observed histologically that low and 
high AGE diets were resulting in the formation of ADH and MIN structures, which 
sustained into adulthood. These pre-neoplastic lesions are structurally similar to 
 
Figure 36. Increased Macrophage Recruitment. Representative images of F4/80 
IHC stained mammary gland tissue sections or regular fed mice (i) from wild type 
mice fed a high AGE diet (ii). High AGE diet showed increased macrophage 
recruitment surrounding pre-neoplastic lesions of the adult glands (iii) as well as 
TEBs during development (ii). 
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formation and structure of human DCIS [31]. These structures stained positive for tissue 
specific AGEs and RAGE, possibly from the upregulation of RAGE caused by 
AGE:RAGE signaling [4, 11, 16]. Increased macrophage recruitment to the gland was 
observed in F4/80 stained glands surrounding developing TEBs and ducts in high AGE 
mice. The increased macrophage recruitment observed may contribute to development 
changes, such as increase TEB number/size and ductal branching seen in Specific Aim 
1. High AGE adult mammary glands stained for F4/80 also revealed increased 
macrophage presence and infiltration in the pre-neoplastic lesions, a common 
characteristic of human DCIS [26, 44, 45]. 
Proliferation was assessed in the developing mammary glands possibly from 
AGE:RAGE signaling leading to pro-proliferation factors being released from 
macrophages, leading to observed phenotypic changes [10, 11, 13, 26, 44, 45]. It was 
observed that a diet high in AGEs led to increased proliferation of TEBs and ducts during 
late puberty as well as increased hyperproliferative duct presence throughout 
development. This increased proliferation was sustained into adulthood as the pre-
neoplastic lesions showed to be proliferative throughout development, a characteristic of 
DCIS [31, 56, 60]. However, we did not assess apoptosis of these structures to 
determine cellular turnover, a future direction we plan to assess using IHC markers of 
apoptosis (e.g. apoptosis inducing factor (AIF), BAX and Caspase-1) 
Structure of the myoepithelial layer was observed via SMA staining to assess if 
the diet high in AGEs was disrupting the layer supporting a more invasive phenotype. 
During pubertal development, it was observed that a pubertal diet high in AGEs led to a 
disruption of the myoepithelial layer in TEBs and ducts, this disruption carried into 
adulthood as the pre-neoplastic lesions in the adult glands showed to have a disruption 
in the myoepithelial cells. This disruption may establish a pre-disposition to aggressive 
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cancer as disruption of the layer is associated with IDC [31, 43, 56]. This disruption may 
result from protein and DNA changes via the pro-oxidant and inflammatory signaling of 
AGE:RAGE, and possible effects sustained to the cap cells of the TEBs or mammary 
stem cells known to differentiate into myoepithelial cells [24, 59, 61]. 
Activated myofibroblasts expressing the marker SMA were also stained while 
looking at myoepithelial structure, the SMA marker is commonly associated with CAFs 
[47]. We observed that high AGE fed mice showed increased activated fibroblasts in the 
stroma of TEBs during development. These activated fibroblasts may also lead to the 
changes we observed in development in Specific Aim 1 as fibroblasts are known to 
secrete factors, such as growth factors, proteases and cytokines aiding in the 
development of the gland as well as recruiting immune cells, such as macrophages. Pre-
neoplastic lesions during puberty and into adulthood of high AGE fed mice showed 
recruitment of activated fibroblasts to the stroma, a common characteristic of human 
DCIS [31, 45-47]. 
Taken together, this data suggests that a pubertal diet high in AGEs leads to a 
recruitment of macrophages and activated fibroblasts to developing structures of 
pubertal mammary glands and increased proliferation, possibly leading to the increased 
TEB number, size and branching as well as the delayed extension we observed in 
Specific Aim 1. A diet high in AGEs also led to the development of pre-neoplastic lesions 
in late puberty which further progressed in adulthood. These lesions shared similar 
characteristics to human DCIS: increased macrophage presence, increased fibroblast 
recruitment and activation, increased proliferation and disruption of the myoepithelial 
layer [31, 45-47]. These changes to development and formation of pre-neoplastic lesions 
may lead to increased breast cancer risk with exposure to oncogenic insult, as seen in 
diets such as high fat and high n-6 PUFA [38, 57].  
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A caveat with the experimental design in this specific aim is the staining for 
macrophages using an F4/80 antibody, which has also been shown to stain eosinophils. 
Eosinophils also play an important role in mammary gland development and possible 
positive staining of macrophages could be eosinophils [28, 29]. However, distinct 
morphological differences help to distinguish between the two cell types. A future 
direction for this aim would be to use a dual stain method to better distinguish between 
macrophage and eosinophil recruitment to structures of the glands using 
immunofluorescence with specific macrophage markers (CD68) and eosinophil markers 
(Siglec-F). Quantification of any IHC stain is imperfect and correlation with positive 
staining and observed changes does not imply a positive connection between the two. 
Even though we see increased macrophage and activated fibroblasts recruitment in 
mice fed the high AGE diet, it is important to investigate the AGE:RAGE signaling 
pathway further to determine by which AGEs and RAGE are inducing the changes to 
development and formation of the pre-neoplastic lesions. We look to investigate this 












 Our collective data show a link between consumption of a high AGE diet with 
significant disruption of normal pubertal mammary gland development, possibly leading 
to increased cancer risk via the formation of pre-neoplastic lesions. However, the exact 
mechanism of these drastic changes is not known and something we look to investigate 
further as well as cancer incidence among the diets (Figure 37). 
 
 Macrophage and Fibroblast Recruitment in High AGE Diet. We first look to 
further establish the recruitment of immune cells and activation of fibroblast to the 
stroma of surrounding developing structures in mice fed a high AGE diet. We plan to 
continue with our normal development model of FVB/n female mice beginning their diets 
at 3 weeks of age, this time feeding them for a period of 4 weeks (7 weeks of age). 
 
Figure 37. Working Hypothesis. Our current working hypothesis of AGE:RAGE 





















































Using co-immunofluorescent staining using markers for stromal cells: macrophages 
(F4/80 and CD68) and fibroblasts (vimentin and FSP1) as well as cells for TEB 
identification: basal myoepithelial cells (αSMA), cap cells (p63) and body cells (E-
cadherin) we look to confirm the recruitment of these stromal cells to TEB structures, as 
well as the cell type that has AGE mediated upregulation of RAGE via co-
immunofluorescent staining using fibroblast and macrophage markers with RAGE. Using 
our 7-week-old mice endpoint we look to define the AGE/RAGE association with the 
activation of macrophages using flow cytometry by co-expression of CD11b/CD68 or 
pro-inflammatory (“M1’) phenotype or tumorigenic (“M2”) from expression of CD86/iNOS 
or CD206/Arginase1 [62]. AGE/RAGE will also be assessed to determine association 
with macrophages. We expect to see increased mis-localized recruitment of 
macrophages to developing structures with a switch to a pro-tumorigenic phenotype in 
high AGE diet compare to regular, AGE/RAGE staining is expected to be seen co-
localized to macrophages in the high AGE diet fed mice. Some effects of low AGE diet 
are expected as they represent an endogenous source of AGE, however the effects are 
expected to be less severe and less prominent in the glands. 
 Fibroblasts Activation in the High AGE Diet. We then plan to further 
understand the AGE/RAGE association with activation and recruitment of fibroblasts to 
TEBS during puberty. Fibroblasts from 7-week-old mice will be identified via common 
markers (FSP/vimentin) and distinctive spindling morphology, we will isolate from 
contaminating stromal and epithelial cell population to establish cell culture. Using flow 
cytometry, western blot and qPCR, activation of fibroblasts will be assessed with FAP 
and COL1A1 expression as they are specific markers of fibroblasts and are upregulated 
in activated fibroblasts [63]. We expect to see increased mis-localized recruitment of 
activated fibroblasts (high FAP/COL1A1, low CD36) to TEBs with a switch to a pro-
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tumorigenic microenvironment in high AGE diet compare to regular. AGE/RAGE staining 
is expected to be co-localized to fibroblasts in the high AGE diet. Effects of low AGE diet 
are expected to be seen (endogenous AGE), however the effects are expected to be 
less severe and less prominent in the glands. 
 Identification of AGE Species in the Mammary Gland. Depending on the 
manner of AGE formation whether it be formed through glycation or oxidation, etc. 
multiple species of AGEs are possible depending on the proteins that are being 
glycated. Variations in the formation of AGEs can vary the pathogenic affect as well as 
the effect on pubertal mammary gland development. Using dot blot, western blot and 
fluorescent cytochemistry, we will look at various species of AGEs using specific 
antibodies to identify potential pathways and mechanism. As AGE formation, can result 
from various mechanisms, such as lipid peroxidation, glucose oxidation, and the Maillard 
reaction, to list a few [1, 2]. We expect to see species-specific AGE presence and 
localization to surrounding epithelial cells or macrophages/fibroblasts providing 
information on the mechanism leading to the change in development and possible pro-
tumorigenic environment. 
 Determine Timing of Phenotypic Change in High AGE Diet. Another direction 
would to be to determine the timing of abnormal development and stromal recruitment 
during pubertal development, using our same model we would collect mice after 
exposure to the diets for 1, 2 and 3 weeks. The mice will be analyzed using similar 
analysis used in the thesis, such as: ductal extension, ductal branching, TEB number 
and size, as well as morphological and stromal changes with H&E. We anticipate that 
changes will occur rather quickly, around the 1 week timepoint with increased 
macrophage recruitment followed by increased fibroblast recruitment as seen in our 
hypothesized mechanism (Figure 37). 
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 Determine the Role of AGE:RAGE Signaling in Observed Phenotypic 
Changes. To determine the mechanism behind our observed changes in development 
we look to verify if the dysregulation is caused from signaling through the AGE:RAGE 
pathway. FVB/n RAGE -/- mice will be fed the diets from weaning (3 weeks) to the 7-
week timepoint, at which point the glands will be assessed as described previously 
comparing all data to FVB/n wild type (RAGE +/+) mice fed the same diets. RAGE -/- 
mice fed a regular diet will be compared to RAGE +/+ mice fed a regular diet as a control 
to see the effects of RAGE loss alone on mammary gland development. 
Using co-culture models of non-transformed mammary epithelial cells (HC11-
Mouse and MCF10A-Human) and isolated fibroblasts/macrophages of RAGE -/- and 
RAGE +/+ mice, we can further assess the need for RAGE in the activation of 
macrophages and fibroblasts. Monitoring the expression/activation levels of various 
signaling pathways such as MAPKs, ERK and the positive feedback loop of RAGE itself 
can further help us understand the mechanism leading the heightened inflammatory 
response (Figure 36). During activation, macrophages and fibroblasts secrete specific 
factors to their function in the developing gland (MMPs, IL-6, TGFβ, FGF2 and PDGF), 
media from macrophages and fibroblasts will be collected to assess the secreted factor 
profile, as well as presence of receptors to assess changes under the influence of AGE 
and RAGE causing a pro-inflammatory and oxidant environment. We anticipate a 
significant proportion of activated fibroblast and macrophages in a pro-tumorigenic state, 
expressing a specific cytokine/chemokine profile. We expect to see an increase in CSF1 
and CSF1R expression as it is the main receptor and ligand expressed in recruitment of 
macrophages to the developing mammary gland, which we believe will increase from the 
pro-inflammatory signaling of AGE:RAGE. We expect to see an increase in IL-6 a key 
regulator of macrophage and fibroblast recruitment/activation [26-29, 33, 34]. 
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We also plan to target RAGE biologically via shRNA and neutralizing antibodies 
as well as pharmacologically (RAGE Antagonist, FPS-ZM1, Calbiochem). This will allow 
us to modulate RAGE in specific cell types before administration of AGEs to assess the 
downstream effects on macrophage and fibroblasts activation. To assess downstream 
signaling pathways, responsive to AGE/RAGE activation, biological and pharmacological 
inhibitors specific for NFκB, AKT and ERK (known effectors of the AGE/RAGE signaling 
axis) will be utilized in the epithelial cells to assess impact of AGE-mediated activation of 
fibroblasts and macrophages. The effects observed on the RAGE -/- and RAGE +/+ 
models on downstream components such as: NFκB, AKT and ERK will add insight into 
the mechanism of AGE induced dysregulation during normal pubertal mammary gland 
development. 
Determine the Impact of Pubertal AGE Ingestion on Breast Cancer 
Incidence. We look to utilize the C3(tetO-TAg) inducible mouse model of cancer 
(017719; Jackson Labs, Bar Harbor, Maine) to assess if feeding a high AGE diet creates 
a pro-tumorigenic microenvironment leading to increased incidence and/or progression 
in response to an additional oncogenic insult. The C3(tetO-TAg) mice will be bred with 
MTB (MMTV-rtTA) mice, which will allow doxycycline (dox)-inducible expression of C3-
TAg specifically in the mammary epithelium. Transgenic C3(tetO-TAg) and bigenic 
C3(tetO-TAg)/MTB mice will be fed regular, low AGE and high AGE diets from weaning 
till maturity (12 weeks of age), at which point they will be given dox water to induce the 
transgene. Mice will be sacrificed at 4, 8, 12 and 16 weeks post-dox induction to assess 
tumor initiation and progression. We anticipate that the high AGE diet will lead to 
accelerated tumor growth and progression, as our data has shown that the high AGE 
diet creates a pro-tumorigenic microenvironment primed for oncogenic insult. 
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Assess the Requirement of RAGE in AGE-Mediated Cancer Progression. The 
C3(tetO-TAg/MTB bigenic mice will be bred to the RAGE -/- mice to create trigenic 
C3(tetO-TAg)/MTB/RAGE-/- and bigenic C3(tetO-TAg)/RAGE-/- control mice, all 
maintained on an FVB/n background. As described above, the mice will be fed the 
regular low and high AGE diets from weaning to adulthood, mice will be sacrificed at 12 
weeks to assess the role of RAGE in the formation of pre-cancerous lesions, and the 
remaining mice will be exposed to dox to induce the transgene. Mice will be analyzed in 
a similar fashion as described to determine the role of RAGE in cancer progression in 
the presence and absence of AGE. Based on published studies, we anticipate that 
RAGE is required for the development of pre-cancerous lesions, with absence of RAGE 
less severe effects of AGE-mediated tumor progression will be observed. 
Significance of Study 
 Previous studies have looked on the effects of diet, such as high-fat diet on 
pubertal mammary gland development with relationship to breast cancer progression in 
adulthood. However, AGEs have been greatly overlooked despite their increased 
presence in our modern day “Western” diet, sedentary lifestyle and increased 
consumption of cheap processed foods. We are the first group to establish this link of 
increased AGE consumption and dysregulation in pubertal mammary gland. Puberty is a 
time of tight regulation, a time where many adolescents are not necessarily thinking 
towards the future of their health and cancer risk. 
This lack of knowledge may lead to complications of development over time, 
dysregulations of similar processes that are seen to contribute to tumorigenesis, a 
consequence we observed in our study. The disruption of development led to structures 
that are similar to cancerous lesions in human breast. Showing that consumption of a 
high AGE diet during puberty may lead to predisposition of breast cancer and increased 
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cancer progression when exposed to oncogenic insult. This groundbreaking insight into 
the effects of AGE on development and breast cancer risk, enforces the importance of 
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